These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 30206323)
21. Plasma levels of the cardiovascular protective endogenous nucleoside adenosine are reduced in patients with primary aldosteronism without affecting ischaemia-reperfusion injury: A prospective case-control study. van den Berg TNAD; Thijssen DHJ; van Mil ACCM; van den Broek PH; Rongen GA; Monajemi H; Deinum J; Riksen NP Eur J Clin Invest; 2019 Dec; 49(12):e13180. PubMed ID: 31659743 [TBL] [Abstract][Full Text] [Related]
23. Hypokalemia correlated with arterial stiffness but not microvascular endothelial function in patients with primary aldosteronism. Chang YY; Chen A; Chen YH; Hung CS; Wu VC; Wu XM; Lin YH; Ho YL; Wu KD; J Renin Angiotensin Aldosterone Syst; 2015 Jun; 16(2):353-9. PubMed ID: 25143326 [TBL] [Abstract][Full Text] [Related]
24. Relative value of computed tomography scanning and venous sampling in establishing the cause of primary hyperaldosteronism. Sheaves R; Goldin J; Reznek RH; Chew SL; Dacie JE; Lowe DG; Ross RJ; Wass JA; Besser GM; Grossman AB Eur J Endocrinol; 1996 Mar; 134(3):308-13. PubMed ID: 8616527 [TBL] [Abstract][Full Text] [Related]
25. Dopaminergic regulation of aldosterone secretion: its pathophysiologic significance in subsets of primary aldosteronism. Naruse M; Naruse K; Yoshimoto T; Tanaka M; Tanabe A; Imaki T; Shibasaki T; Demura R; Demura H Hypertens Res; 1995 Jun; 18 Suppl 1():S59-64. PubMed ID: 8529076 [TBL] [Abstract][Full Text] [Related]
26. Have main types of primary aldosteronism different phenotype? Somlóová Z; Indra T; Rosa J; Petrák O; Strauch B; Zelinka T; Holaj R; Widimský J Physiol Res; 2012; 61(4):431-6. PubMed ID: 22670702 [TBL] [Abstract][Full Text] [Related]
27. Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma. Rossi GP; Belfiore A; Bernini G; Desideri G; Fabris B; Ferri C; Giacchetti G; Letizia C; Maccario M; Mallamaci F; Mannelli M; Montemurro D; Palumbo G; Rizzoni D; Rossi E; Semplicini A; Agabiti-Rosei E; Pessina AC; Mantero F; J Hypertens; 2007 Jul; 25(7):1433-42. PubMed ID: 17563566 [TBL] [Abstract][Full Text] [Related]
28. Effect of naloxone on the adrenal cortex in primary aldosteronism. Fallo F; Boscaro M; Sonino N; Mantero F Am J Hypertens; 1988 Jul; 1(3 Pt 1):280-2. PubMed ID: 2839206 [TBL] [Abstract][Full Text] [Related]
29. Vascular complications in patients with aldosterone producing adenoma in Japan: comparative study with essential hypertension. The Research Committee of Disorders of Adrenal Hormones in Japan. Takeda R; Matsubara T; Miyamori I; Hatakeyama H; Morise T J Endocrinol Invest; 1995 May; 18(5):370-3. PubMed ID: 7594226 [TBL] [Abstract][Full Text] [Related]
30. Effect of verapamil on aldosterone secretion in primary aldosteronism. Opocher G; Rocco S; Murgia A; Mantero F J Endocrinol Invest; 1987 Oct; 10(5):491-4. PubMed ID: 3429788 [TBL] [Abstract][Full Text] [Related]
31. [The long-term administration of dexamethasone for the differentiation of the 4 types of hyperaldosteronism]. Watanabe Y; Fukuchi S Nihon Naibunpi Gakkai Zasshi; 1995 Mar; 71(2):149-66. PubMed ID: 7750627 [TBL] [Abstract][Full Text] [Related]
32. Reduction in blood pressure improves impaired nitroglycerine-induced vasodilation in patients with essential hypertension. Maruhashi T; Nakashima A; Kishimoto S; Iwamoto A; Kajikawa M; Oda N; Kihara Y; Aibara Y; Noma K; Higashi Y Hypertens Res; 2015 Dec; 38(12):862-8. PubMed ID: 26333358 [TBL] [Abstract][Full Text] [Related]
33. Impaired flow-mediated vasodilation in type 2 diabetes: lack of relation to microvascular dysfunction. Meyer MF; Lieps D; Schatz H; Pfohl M Microvasc Res; 2008 May; 76(1):61-5. PubMed ID: 18448131 [TBL] [Abstract][Full Text] [Related]
34. Dissociation of plasma atrial natriuretic peptide responses to upright posture and furosemide administration in patients with normal-, low renin essential hypertension and primary aldosteronism. Sergev O; Rácz K; Varga I; Kiss R; Fütö L; Gutkowska J; Gláz E Clin Exp Hypertens A; 1991; 13(3):409-23. PubMed ID: 1832596 [TBL] [Abstract][Full Text] [Related]
35. The syndromes of low-renin hypertension: "separating the wheat from the chaff". Kater CE; Biglieri EG Arq Bras Endocrinol Metabol; 2004 Oct; 48(5):674-81. PubMed ID: 15761538 [TBL] [Abstract][Full Text] [Related]
37. The metabolic phenotype of patients with primary aldosteronism: impact of subtype and sex - a multicenter-study of 3566 Caucasian and Asian subjects. Spyroglou A; Handgriff L; Müller L; Schwarzlmüller P; Parasiliti-Caprino M; Fuss CT; Remde H; Hirsch A; O'Toole SM; Thuzar M; Petramala L; Letizia C; Deflorenne E; Amar L; Vrckovnik R; Kocjan T; Zhang CD; Li D; Singh S; Katabami T; Yoneda T; Murakami M; Wada N; Inagaki N; Quinkler M; Ghigo E; Maccario M; Stowasser M; Drake WM; Fassnacht M; Bancos I; Reincke M; Naruse M; Beuschlein F Eur J Endocrinol; 2022 Sep; 187(3):361-372. PubMed ID: 35895721 [TBL] [Abstract][Full Text] [Related]
38. Macrovascular and microvascular function after implantation of left ventricular assist devices in end-stage heart failure: Role of microparticles. Sansone R; Stanske B; Keymel S; Schuler D; Horn P; Saeed D; Boeken U; Westenfeld R; Lichtenberg A; Kelm M; Heiss C J Heart Lung Transplant; 2015 Jul; 34(7):921-32. PubMed ID: 25980571 [TBL] [Abstract][Full Text] [Related]